Cibus, Inc. Class A

Stage 4 · Declining · week 4

As of Oct 22, 2026, Cibus is in Stage 4, the downtrend phase, now in week 4 (since Sep 25, 2026). It closed at $1.40, 65.4% below its 52-week high and below its 200-day average, which is falling.

Cibus, Inc. is an agricultural biotechnology company that develops and licenses gene-edited plant traits. More about the company

$1.40

+6.06% today

$107M · Micro cap

Market Neutral — Building

Pro read

Pro

Our read

Declining, below its long-term trend

Setup score

—

Momentum

Steady

Edge

—

Is CBUS early, or has it already run? Pro answers that for every US stock we cover, after every close.

Get Pro · $19 a month

Renews monthly until you cancel. Cancel any time in Plan & billing.

Loading price chart…

Stage Cycle Timeline2023-08-16 → 2026-10-22

S4 26w

S4 19w

S4 18w

2023-08-162026-10-22

S1S2S3S4Setup score (0–10, dashed line at 5)

S3 4w → S2 3w → S3 1w → S4 12w → S1 6w → S2 10w → S3 5w → S4 26w → S1 3w → S4 19w → S1 5w → S4 18w → S1 4w → S4 2w → S1 7w → S2 11w → S3 5w → S4 7w → S1 10w → S4 4w current

Total tracked: 165 weeks across 20 stage runs.

CBUS among Biotechnology215th of 591 by relative strength

All 591 →

Stocks in Biotechnology ranked by relative strength, with stage and one-month change
#	Stock	Stage	RS	1M
1	GTBPGT Biopharma, Inc.	Stage 2 · wk 7	99	−22.3%
2	IOVAIovance Biotherapeutics, Inc.	Stage 2 · wk 18	99	+38.8%
3	SLSSELLAS Life Sciences Group, Inc.	Stage 3 · wk 4	99	−1.5%
4	MRNAModerna, Inc.	Stage 2 · wk 17	99	+11.3%
5	TWSTTwist Bioscience Corporation	Stage 2 · wk 39	99	−14.5%
6	KODKodiak Sciences Inc	Stage 2 · wk 4	99	+172.1%
7	ERASErasca, Inc.	Stage 3 · wk 5	99	+0.7%
8	CLYMClimb Bio, Inc.	Stage 3 · wk 3	99	−15.8%
…215	CBUSCibus, Inc. Class A	Stage 4 · wk 4	47	−9.1%

vs 52W High

-65.4%

$1.16 lo$4.05 hi

65.4% below 52W high, deep Stage 4 damage

In Stage 4, distance from the 52-week high reflects an ongoing decline, not a discount.

Stage Maturity

Week 4

1w13w26w

Week 4, early Stage 4 decline

How long this stock has been in Stage 4 decline. The longer the downtrend, the more entrenched the selling pressure. No length of decline marks a bottom on its own.

vs 200 DMA

-25.0%

200 DMA: $1.87 · sloping down

In Stage 4, the stock is below its 200-day average, the hallmark of a downtrend. Stage analysis waits for that to reverse before buying.

Rel Volume

0.40x

vs 50-day avg

High volume on down days in Stage 4 confirms institutional selling. Low-volume bounces are typical. They lack real buyers and are easy to mistake for reversals.

Trend Health

↓

Short-term trend rolling over

Two reads of momentum. The arrow shows the direction of the short-term trend: rising (↑ or ↗), flat (→) or rolling over (↓). The ⇈ mark appears when our trend model reads the move as gaining speed on top of the longer trend. Strongest when both agree.

-9.1%

-17.6%

-3.4%

YTD

-25.5%

-9.7%

Scan Membership

Breakout Watch

Latest: 2024-02-21

8 appearances in last 60 days. First seen: 2019-03-29.

A stock that keeps qualifying week after week does so because its Stage 2 structure keeps holding. Staying power in the scan says more about the trend than any single appearance.

Recent Stage Timeline

2026-10-22S4

Wk 4 · Vol 0.40x

2026-10-21S4

Wk 4 · Vol 0.35x

2026-10-20S4

Wk 4 · Vol 0.46x

2026-10-19S4

Wk 4 · Vol 0.29x

2026-10-16S4

Wk 4 · Vol 0.36x

2026-10-15S4

Wk 3 · Vol 0.61x

2026-10-14S4

Wk 3 · Vol 0.82x

2026-10-13S4

Wk 3 · Vol 0.34x

2026-10-12S4

Wk 3 · Vol 0.68x

2026-10-09S4

Wk 3 · Vol 0.32x

2026-10-08S4

Wk 2 · Vol 1.09x

2026-10-07S4

Wk 2 · Vol 0.72x

Moving averages & range

50 DMA

$1.57

200 DMA

$1.87

52W High

$4.05

52W Low

$1.16

5D Low

$1.31

Resistance levels (recent highs)

20d High

$1.71

60d High

$1.93

120d High

$2.39

250d High

$4.05

Next resistance

+22.1%

to 20d High

ROE

-223.2%

Profit margin 0.0%

Dividend Yield

0.00%

P/B 7.2

Cibus: quick answers

What stage is Cibus in?

As of Oct 22, 2026, Cibus (CBUS) is in Stage 4, the downtrend phase. It entered Stage 4 on Sep 25, 2026 and is in week 4. What the four stages mean

Is Cibus in an uptrend?

No. Cibus is in a Stage 4 downtrend. It trades 25.0% below its 200-day average, which is falling.

How far is Cibus from its 52-week high?

Cibus closed at $1.40 on Oct 22, 2026, 65.4% below its 52-week high of $4.05. Its 52-week low is $1.16.

How has Cibus performed over the past year?

As of Oct 22, 2026, Cibus is down 9.7% over the past year and down 25.5% so far in 2026.

Which sector and industry is Cibus in?

Cibus is in the Biotechnology industry, part of the Health Care sector.

About this companyHealth Care· Biotechnology

Cibus, Inc. is an agricultural biotechnology company that develops and licenses gene-edited plant traits. The company's products enable farmers to achieve higher yields and reduce the use of chemicals, such as fungicides, insecticides and fertilizers, and offer sustainable ingredients. it has patented core technology platform, RTDS, a scalable, standardized, end-to-end, semi-automated and high-throughput gene-editing system marketed under the Trait Machine brand name. The company was formerly known as Calyxt, Inc. and changed its name to Cibus, Inc. in June 2023. Cibus, Inc. was incorporated in 2010 and is headquartered in San Diego, California.

Visit company website →

All analytics based on EOD data. Data as of 2026-10-22. Past data patterns are not indicative of future results. This page is a data analytics tool only.